Devices › Device types
FDA product code EOB · class 2 · Ear, Nose, Throat
Nasopharyngoscope (flexible or rigid): medical device reports filed with FDA
8,127 reports carry this product code, 2001–2026; 15 brands with a page.
- 8,127
- reports with this product code
- 0% of all MAUDE reports
- 2,828
- reports, 12 months to August 2026
- 1,231 in the 12 months before
- 98.6%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code EOB is FDA's classification for "Nasopharyngoscope (flexible or rigid)" (ear, Nose, Throat panel), a class 2 device. 8,127 medical device reports carry this product code, 0% of the MAUDE database, from February 2001 to August 2026.
2,828 reports arrived in the 12 months to August 2026, up 130% from 1,231 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.6%) and injury (1.3%). 15 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Pentax | 4,349 | 2,443 | 0.1% | 98.4% |
| Rhino-Laryngo Videoscope | 1,925 | 1,452 | 0% | 99.5% |
| Rhino-Laryngofiberscope | 331 | 287 | 0% | 99.1% |
| Visera Rhino-Laryngo Videoscope | 283 | 194 | 0% | 99.6% |
| Rhino-Laryngo Fiberscope | 267 | 145 | 0% | 99.6% |
| PENTAX Medical | 264 | 807 | 0.3% | 96% |
| Videoarthroscope Hd 4mm X 30 Deg | 22 | 0 | 0% | 97.2% |
| 4k C-Mnt Scp 4 0 30 167 Mitek | 12 | 205 | 0% | 100% |
| Endoeye Flex Deflectable Videoscope | 4 | 2,245 | 0% | 99.5% |
| Bronchovideoscope | 3 | 938 | 0.1% | 98.6% |
| Single Use Suction Valve Sterile | 3 | 0 | 0% | 98.2% |
| Disposable Biopsy Forceps | 2 | 8 | 0% | 45.3% |
| Hd Epscp 4 0 30 167 Mitek | 1 | 27 | 0% | 100% |
| SINGLE USE BIOPSY VALVE (Sterile) | 1 | 130 | 0% | 51.2% |
| VISERA Pro VIDEO SYSTEM CENTER | 1 | 96 | 0% | 99.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Hoya Pentax Tokyo Office | 4,642 | 57.1% |
| Shirakawa Olympus | 2,317 | 28.5% |
| Olympus Winter & Ibe | 80 | 1% |
| Aizu Olympus | 76 | 0.9% |
| Karl Storz Se & Kg | 75 | 0.9% |
| Medos International S Rl | 16 | 0.2% |
| Medtronic Xomed | 6 | 0.1% |
| Olympus Medical Systems Hinode Plant | 3 | 0% |
| Gyrus Acmi | 2 | 0% |
| Medtronic Dominicana | 1 | 0% |
| Olympus Medical System | 1 | 0% |
| Richard Wolf | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 1,933 | 23.8% |
| Fluid/blood leak | 1,350 | 16.6% |
| No display/image | 830 | 10.2% |
| Detachment of device or device componentpart of the device came off | 728 | 9% |
| Failure to clean adequately | 484 | 6% |
| Erratic or intermittent display | 343 | 4.2% |
| Optical obstruction | 294 | 3.6% |
| Device reprocessing problem | 291 | 3.6% |
| Peeled/delaminated | 264 | 3.2% |
| Corrodedthe device corroded | 201 | 2.5% |
| Material fragmentation | 190 | 2.3% |
| Loss of or failure to bond | 135 | 1.7% |
| Optical distortion | 127 | 1.6% |
| Crackthe device cracked | 124 | 1.5% |
| Poor quality image | 110 | 1.4% |
| Material split, cut or torn | 100 | 1.2% |
| Material separation | 98 | 1.2% |
| Degraded | 95 | 1.2% |
| Contamination | 91 | 1.1% |
| Residue after decontamination | 81 | 1% |
Questions about nasopharyngoscope (flexible or rigid) reports
What is product code EOB?
FDA's classification code for "Nasopharyngoscope (flexible or rigid)", class 2, reviewed by the ear, Nose, Throat panel. Every device report carries the product code of the device involved.
How many reports carry this code?
8,127 reports through August 2026, 2,828 of them in the latest 12 months.
Which brands appear most often?
Pentax (4,349), Rhino-Laryngo Videoscope (1,925), Rhino-Laryngofiberscope (331), Visera Rhino-Laryngo Videoscope (283) and Rhino-Laryngo Fiberscope (267). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.